APA (7th ed.) Citation

CL, C., JF, H., JS, R., H, K., J, M., & SR, L. (2008). Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir. Current HIV research, 6(3), 272. https://doi.org/10.2174/157016208784324967

Chicago Style (17th ed.) Citation

CL, Cherry, Hoy JF, Rowe JS, Krum H, Mills J, and Lewin SR. "Phase 1 Single Dose Studies to Optimize the Pharmacokinetics of DG17, a Novel HIV-protease Inhibitor Pro-drug, Using Sodium Bicarbonate and Ritonavir." Current HIV Research 6, no. 3 (2008): 272. https://doi.org/10.2174/157016208784324967.

MLA (9th ed.) Citation

CL, Cherry, et al. "Phase 1 Single Dose Studies to Optimize the Pharmacokinetics of DG17, a Novel HIV-protease Inhibitor Pro-drug, Using Sodium Bicarbonate and Ritonavir." Current HIV Research, vol. 6, no. 3, 2008, p. 272, https://doi.org/10.2174/157016208784324967.